120 related articles for article (PubMed ID: 36177826)
21. Ruthenium(II) Complex Incorporated UiO-67 Metal-Organic Framework Nanoparticles for Enhanced Two-Photon Fluorescence Imaging and Photodynamic Cancer Therapy.
Chen R; Zhang J; Chelora J; Xiong Y; Kershaw SV; Li KF; Lo PK; Cheah KW; Rogach AL; Zapien JA; Lee CS
ACS Appl Mater Interfaces; 2017 Feb; 9(7):5699-5708. PubMed ID: 28121418
[TBL] [Abstract][Full Text] [Related]
22. Synergistic effect of dual targeting vaccine adjuvant with aminated β-glucan and CpG-oligodeoxynucleotides for both humoral and cellular immune responses.
Jin JW; Tang SQ; Rong MZ; Zhang MQ
Acta Biomater; 2018 Sep; 78():211-223. PubMed ID: 30098441
[TBL] [Abstract][Full Text] [Related]
23. A simple and powerful co-delivery system based on pH-responsive metal-organic frameworks for enhanced cancer immunotherapy.
Duan F; Feng X; Yang X; Sun W; Jin Y; Liu H; Ge K; Li Z; Zhang J
Biomaterials; 2017 Apr; 122():23-33. PubMed ID: 28107662
[TBL] [Abstract][Full Text] [Related]
24. Engineering a curcumol-loaded porphyrinic metal-organic framework for enhanced cancer photodynamic therapy.
Zhang M; Shen W; Jiang Q; Sun Q; Liu Y; Yang Y; Yin D
Colloids Surf B Biointerfaces; 2022 Jun; 214():112456. PubMed ID: 35290822
[TBL] [Abstract][Full Text] [Related]
25. Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.
Liu HM; Newbrough SE; Bhatia SK; Dahle CE; Krieg AM; Weiner GJ
Blood; 1998 Nov; 92(10):3730-6. PubMed ID: 9808567
[TBL] [Abstract][Full Text] [Related]
26. Retraction Notice to: Nanoscale Metal-Organic Framework Mediates Radical Therapy to Enhance Cancer Immunotherapy.
Ni K; Aung T; Li S; Fatuzzo N; Liang X; Lin W
Chem; 2023 Mar; 9(3):755. PubMed ID: 37794982
[TBL] [Abstract][Full Text] [Related]
27. A Cu
Zhou L; Chen L; Hu X; Lu Y; Liu W; Sun Y; Yao T; Dong C; Shi S
Commun Biol; 2020 Jul; 3(1):343. PubMed ID: 32620811
[TBL] [Abstract][Full Text] [Related]
28. Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy.
Liang Z; Cui X; Yang L; Hu Q; Li D; Zhang X; Han L; Shi S; Shen Y; Zhao W; Ju Q; Deng X; Wu Y; Sheng W
Int J Pharm; 2021 Oct; 608():121091. PubMed ID: 34555477
[TBL] [Abstract][Full Text] [Related]
29. Chitosan-coated boron nitride nanospheres enhance delivery of CpG oligodeoxynucleotides and induction of cytokines.
Zhang H; Chen S; Zhi C; Yamazaki T; Hanagata N
Int J Nanomedicine; 2013; 8():1783-93. PubMed ID: 23674892
[TBL] [Abstract][Full Text] [Related]
30. Cationic Flexible Organic Framework for Combination of Photodynamic Therapy and Genetic Immunotherapy Against Tumors.
Hao K; Lin L; Sun P; Hu Y; Atsushi M; Guo Z; Tian H; Chen X
Small; 2021 May; 17(19):e2008125. PubMed ID: 33760358
[TBL] [Abstract][Full Text] [Related]
31. Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.
Wooldridge JE; Ballas Z; Krieg AM; Weiner GJ
Blood; 1997 Apr; 89(8):2994-8. PubMed ID: 9108420
[TBL] [Abstract][Full Text] [Related]
32. Nanoscale Metal-Organic Framework Co-delivers TLR-7 Agonists and Anti-CD47 Antibodies to Modulate Macrophages and Orchestrate Cancer Immunotherapy.
Ni K; Luo T; Culbert A; Kaufmann M; Jiang X; Lin W
J Am Chem Soc; 2020 Jul; 142(29):12579-12584. PubMed ID: 32658476
[TBL] [Abstract][Full Text] [Related]
33. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure.
Jain VV; Businga TR; Kitagaki K; George CL; O'Shaughnessy PT; Kline JN
Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1137-46. PubMed ID: 12857672
[TBL] [Abstract][Full Text] [Related]
34. Noninvasive and efficient transdermal delivery of CpG-oligodeoxynucleotide for cancer immunotherapy.
Kigasawa K; Kajimoto K; Nakamura T; Hama S; Kanamura K; Harashima H; Kogure K
J Control Release; 2011 Mar; 150(3):256-65. PubMed ID: 21256903
[TBL] [Abstract][Full Text] [Related]
35. Copper-Gallic Acid Nanoscale Metal-Organic Framework for Combined Drug Delivery and Photodynamic Therapy.
Sharma S; Mittal D; Verma AK; Roy I
ACS Appl Bio Mater; 2019 May; 2(5):2092-2101. PubMed ID: 35030648
[TBL] [Abstract][Full Text] [Related]
36. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
[TBL] [Abstract][Full Text] [Related]
37. Self-assembled CpG oligodeoxynucleotides conjugated hollow gold nanospheres to enhance cancer-associated immunostimulation.
Luo J; Cheng Y; He XY; Liu Y; Peng N; Gong ZW; Wu K; Zou T
Colloids Surf B Biointerfaces; 2019 Mar; 175():248-255. PubMed ID: 30540972
[TBL] [Abstract][Full Text] [Related]
38. B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides.
Jahrsdorfer B; Mühlenhoff L; Blackwell SE; Wagner M; Poeck H; Hartmann E; Jox R; Giese T; Emmerich B; Endres S; Weiner GJ; Hartmann G
Clin Cancer Res; 2005 Feb; 11(4):1490-9. PubMed ID: 15746051
[TBL] [Abstract][Full Text] [Related]
39. Nanoscale Metal-Organic Frameworks for Phototherapy of Cancer.
Lan G; Ni K; Lin W
Coord Chem Rev; 2019 Jan; 379():65-81. PubMed ID: 30739946
[TBL] [Abstract][Full Text] [Related]
40. A novel emulsion-type adjuvant containing CpG oligodeoxynucleotides enhances CD8+ T-cell-mediated anti-tumor immunity.
Song YC; Cheng HY; Leng CH; Chiang SK; Lin CW; Chong P; Huang MH; Liu SJ
J Control Release; 2014 Jan; 173():158-65. PubMed ID: 24177312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
